Hypoglycemia in Children: Major Endocrine-Metabolic Causes and Novel Therapeutic Perspectives

Alessia Quarta1, Daniela Iannucci1, Miriana Guarino1

  • 1Department of Pediatrics, University of Chieti-Pescara, Gabriele D'Annunzio, 66100 Chieti, Italy.

Nutrients
|August 26, 2023
PubMed

Insights

Hypoglycemia in children is a metabolic-endocrine emergency with serious risks. Diagnosis requires laboratory tests, endocrine assessments, and genetic analysis for effective management.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Clinical Diagnosis

Background:

  • Hypoglycemia arises from metabolic system defects during fed-fasting transitions or hormonal dysregulation.
  • In children, it's a critical metabolic-endocrine emergency with potential for severe neurological damage and mortality.
  • Nonspecific symptoms, especially in infants, complicate early recognition.

Purpose of the Study:

  • To review age-related definitions of hypoglycemia.
  • To elucidate the pathophysiology and primary causes of hypoglycemia.
  • To discuss current diagnostic strategies and modern therapeutic interventions.

Main Methods:

  • This narrative review synthesizes existing literature.
  • It covers definitions, pathophysiology, causes, diagnosis, and treatment of hypoglycemia.
  • Age-specific considerations are highlighted.

Main Results:

  • Hypoglycemia definitions vary by age.
  • Pathophysiology involves metabolic and hormonal control failures.
  • Diagnosis integrates laboratory, endocrine, and genetic testing.

Conclusions:

  • Prompt diagnosis and management of pediatric hypoglycemia are crucial to prevent severe outcomes.
  • A comprehensive diagnostic approach is essential.
  • Modern therapies aim to mitigate risks and improve patient outcomes.

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
296
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
310
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
989
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
1.3K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
205